Nomura Asset Management CO LTD Ascendis Pharma A/S Transaction History
Nomura Asset Management CO LTD
- $28.9 Billion
- Q2 2024
A detailed history of Nomura Asset Management CO LTD transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 12,629 shares of ASND stock, worth $1.85 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,629
Previous 13,929
9.33%
Holding current value
$1.85 Million
Previous $2.11 Million
18.19%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding ASND
# of Institutions
223Shares Held
56.5MCall Options Held
142KPut Options Held
259K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.48 Billion20.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.96MShares$726 Million3.41% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.3MShares$628 Million0.93% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.2MShares$614 Million7.81% of portfolio
-
Janus Henderson Group PLC London, X03.92MShares$573 Million0.29% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $8.16B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...